Clinical Trial Update: Botulinum Toxin Injection for the Management of BPH [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on botulinum toxin injection for managing benign prostatic hyperplasia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2013-06-24